Download template (57K)
Download all case studies (285K)
BRCA genes in cancer; improved screening regimes and novel therapies (123K)
Enabling the development of PKB inhibitors as novel cancer therapeutics (63K)
Establishing the spin out company Domainex to exploit novel protein expression technology (64K)
RAS/RAF/MEK/ERK signalling and identifying BRAF as a key target for the development of novel cancer therapeutics (65K)